XML 31 R21.htm IDEA: XBRL DOCUMENT
v3.22.2.2

Share-Based Compensation | 6 Months Ended
--- | ---
Jul. 30, 2022
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] |
Share-Based Compensation | Note 14 – Share-Based Compensation We have one equity incentive plan from which we are authorized to grant equity awards, the AstroNova, Inc. 2018 Equity Incentive Plan (the “2018 Plan”). The 2018 Plan provides for, among other things, the issuance of awards, including incentive stock options, non-qualified stock options, stock appreciation rights, time-based restricted stock units (“RSUs”), or performance-based restricted stock units (“PSUs”) and restricted stock awards (RSAs). The 2018 Plan authorizes the issuance of up to 950,000 shares of common stock, plus an additional number of shares equal to the number of shares subject to awards granted under previous equity incentive plans that are forfeited, canceled , satisfied without the issuance of stock, otherwise terminated (other than by exercise), or, for shares of stock issued pursuant to any unvested award, that are reacquired by us at not more than the grantee’s purchase price (other than by exercise). Under the 2018 Plan, all awards to employees generally have a minimum vesting period of one year. Options granted under the 2018 Plan must be issued at an exercise price of not less than the fair market value of our common stock on the date of grant and expire after ten years. Under the 2018 Plan, there were 129,363 unvested RSUs; 128,793 unvested PSUs; 21,172 unvested RSAs and options to purchase an aggregate of 135,500 shares outstanding as of July 30, 2022. In addition to the 2018 Plan, we previously granted equity awards under our 2015 Equity Incentive Plan (the “2015 Plan”) and our 2007 Equity Incentive Plan (the “2007 Plan”). No new awards may be issued under either the 2007 or 2015 plans, but outstanding awards will continue to be governed by those plans. As of July 30, 2022, options to purchase an aggregate of 308,274 shares were outstanding under the 2007 Plan and options to purchase an aggregate of 135,325 shares were outstanding under the 2015 Plan. We also have a Non-Employee Director Annual Compensation Program (the “Program”), under which each of our non-employee directors automatically receives a grant of restricted stock on the date of their re-election to our board of directors. The number of whole shares granted is equal to the number calculated by dividing the stock component of the director compensation amount determined by the compensation committee for that year by the fair market value of our stock on that day. The value of the restricted stock award for fiscal 2023 is $65,000. Shares of restricted stock granted under the Program become vested on the first anniversary of the date of grant, conditioned upon the recipient’s continued service on our board of directors through that date. Share-based compensation expense was recognized as follows:
|  | Three Months Ended |  |  | Six Months Ended |
(In thousands) |  | July 30, 2022 |  |  | July 31, 2021 |  |  | July 30, 2022 |  |  | July 31, 2021 |
Stock Options |  | $ | 1 |  |  | $ | 57 |  |  | $ | 7 |  |  | $ | 162 |
Restricted Stock Awards and Restricted Stock Units |  |  | 234 |  |  |  | 408 |  |  |  | 562 |  |  |  | 778 |
Employee Stock Purchase Plan |  |  | — |  |  |  | 4 |  |  |  | 3 |  |  |  | 7 |
Total |  | $ | 235 |  |  | $ | 469 |  |  | $ | 572 |  |  | $ | 947 |
Stock Options Aggregated information regarding stock option activity for the six months ended July 30, 2022 is summarized below:
|  | Number of Options |  |  | Weighted Average Exercise Price |
Outstanding at January 31, 2022 |  |  | 598,043 |  |  | $ | 14.67 |
Exercised |  |  | (11,444 | ) |  |  | 9.51 |
Forfeited |  |  | (5,100 | ) |  |  | 15.38 |
Expired |  |  | (2,400 | ) |  |  | 8.09 |
Outstanding at July 31, 2021 |  |  | 579,099 |  |  | $ | 14.79 |
Set forth below is a summary of options outstanding at July 30, 2022:
Outstanding |  |  | Exercisable |
Range of Exercise prices |  | Number of Options |  |  | Weighted- Average Exercise Price |  |  | Weighted- Average Remaining Contractual Life |  |  | Number of Options |  |  | Weighted- Average Exercise Price |  |  | Weighted Average Remaining Contractual Life |
$5.00-10.00 |  |  | 25,000 |  |  | $ | 7.91 |  |  |  | 0.1 |  |  |  | 25,000 |  |  | $ | 7.91 |  |  |  | 0.1 |
$10.01-15.00 |  |  | 339,549 |  |  | $ | 13.62 |  |  |  | 3.4 |  |  |  | 340,549 |  |  | $ | 13.62 |  |  |  | 3.4 |
$15.01-20.00 |  |  | 214,550 |  |  | $ | 17.45 |  |  |  | 5.3 |  |  |  | 214,550 |  |  | $ | 17.45 |  |  |  | 5.3 |
|  |  | 579,099 |  |  | $ | 14.79 |  |  |  | 4.0 |  |  |  | 579,099 |  |  | $ | 14.79 |  |  |  | 4.0 |
There were no stock options granted in either fiscal 2022 or during the six months ended July 30, 2022, and as of July 30 , 2022, there was no unrecognized compensation expense related to stock options. Restricted Stock Units (RSUs) and Restricted Stock Awards (RSAs) Aggregated information regarding RSU and RSA activity for the six months ended July 30, 2022 is summarized below:
|  | RSAs & RSUs |  |  | Weighted Average Grant Date Fair Value |
Outstanding at January 31, 2022 |  |  | 199,342 |  |  | $ | 12.63 |
Granted |  |  | 163,009 |  |  |  | 12.77 |
Vested |  |  | (81,923 | ) |  |  | 13.42 |
Forfeited |  |  | (1,100 | ) |  |  | 11.77 |
Outstanding at July 30, 2022 |  |  | 279,328 |  |  | $ | 12.48 |
As of July 30, 2022, there was approximately $1.7 million of unrecognized compensation expense related to RSUs and RSAs which is expected to be recognized over a weighted average period of 1.2 years. Employee Stock Purchase Plan On June 7, 2022, we adopted the AstroNova Inc., 2022 Employee Stock Purchase Plan (“2022 ESPP”) to replace our previous Employee Stock Purchase Plan (the “Prior ESPP”). The 2022 ESPP allows eligible employees to purchase shares of common stock at a 15% discount from fair value on the first or last day of an offering period, whichever is less. A total of 40,000 shares were reserved for issuance under this plan. No shares were purchased under the 2022 ESSP during the six month period ended July 30, 2022. During the six month periods ended July 30, 2022 and July 31, 2021, there were 1,550 and 3,899 shares, respectively, purchased under the Prior ESPP, and no additional purchases may be made under that plan. As of July 30, 2022 , 40,000 shares remain available for purchase under the 2022 ESPP.

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI https://asc.fasb.org/topic&trid=2228938 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (l) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 Reference 4: http://www.xbrl.org/2003/role/exampleRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a)(1) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(2)(i) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(2) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration